Cite
HARVARD Citation
Sonneveld, P. et al. (2023). Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology. 41 (8), pp. 1600-1609. [Online].